T-knife Revenue and Competitors

Berlin, Germany

Location

$197.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • T-knife's estimated annual revenue is currently $18.3M per year.(i)
  • T-knife's estimated revenue per employee is $155,000
  • T-knife's total funding is $197.4M.

Employee Data

  • T-knife has 118 Employees.(i)
  • T-knife grew their employee count by 7% last year.

T-knife's People

NameTitleEmail/Phone
1
Executive Director, Business Development and Strategic FinanceReveal Email/Phone
2
CMOReveal Email/Phone
3
COOReveal Email/Phone
4
CSOReveal Email/Phone
5
CTO and co-founderReveal Email/Phone
6
VP Regulatory AffairsReveal Email/Phone
7
VP, Information Technology & US FacilitiesReveal Email/Phone
8
VP Regulatory AffairsReveal Email/Phone
9
General CounselReveal Email/Phone
10
VP CMC Operations EUReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.9M2389%N/AN/A
#2
$33.7M174-10%$521.9MN/A
#3
$52.4M33815%N/AN/A
#4
$162.7M121933%N/AN/A
#5
$43.2M2797%N/AN/A
#6
$1.1M7N/AN/AN/A
#7
$24.2M15610%N/AN/A
#8
$19.7M1278%N/AN/A
#9
$21.2M13712%$347.1MN/A
#10
$18.3M1187%$197.4MN/A
Add Company

What Is T-knife?

T-knife is a German biotech company developing T cell receptors (TCRs) for T cell therapy of cancer which are derived from T-knife’s proprietary Humanized TCR Mice platform.

keywords:N/A

$197.4M

Total Funding

118

Number of Employees

$18.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

T-knife News

2022-04-20 - Amazon Shoppers Love the Master Maison 19-Piece Knife ...

It can be difficult to wade through the infinite options online to find knives that won't dull or break over time, but more than 7,100...

2022-04-19 - Officers Use Tasers Against Suspect Who Allegedly Wouldn’t Drop Knife In Tracy

TRACY (CBS13) – Officers say they were forced to use their Tasers on a suspect who allegedly wouldn't drop his knife during a chaotic...

2022-04-06 - T-knife Therapeutics Announces New TCR-T Program ...

SAN FRANCISCO, April 08, 2022 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel...

2021-08-10 - Digital health news, funding roundup in the prior week; August 9

PepGen raised $112.5M; Lucid Lane landed $16M; Kensho Health secured $3.5M; DynamiCare Health picks T-knife Therapeutics: T-knife Therapeutics is a Berlin-based, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor therapies. T-knife Therapeutics raised $110 mi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.8M118-34%N/A
#2
$38.9M118-9%N/A
#3
$18.9M11826%N/A
#4
$18.9M118-24%N/A
#5
$28.9M119-3%N/A